0
Editorial |

Press for an Underestimated Nemesis

John A. Carucci, MD, PhD1
[+] Author Affiliations
1Mohs Micrographic and Dermatologic Surgery, Ronald O. Perelman Department of Dermatology, New York University–Langone Medical Center, New York
JAMA Dermatol. 2013;149(10):1147-1148. doi:10.1001/jamadermatol.2013.5273.
Text Size: A A A
Published online

Extract

“Thank goodness it’s not a melanoma!” Many of us may have said or thought that when explaining the diagnosis of a nonmelanoma skin cancer to a patient. We would do well to avoid the temptation to underestimate cutaneous squamous cell carcinoma (SCC). Dermatologists, head and neck surgeons, medical and surgical oncologists, and transplant physicians are aware that cutaneous SCC can and does behave aggressively and has the potential to metastasize.13 Recent studies have shown that the death rate for SCC approaches that for melanoma in parts of the United States.4 Other studies have defined risk factors for especially aggressive behavior by SCC that include large size; deep invasion; and involvement of nerves, lymphatics, and blood vessels.5,6 Some groups, including our own, have set out to define SCC at the molecular level, with the aim of identifying mechanisms of cancer development, progression, and immunity.714 The natural progression of this work would be to define and test novel therapies for advanced SCC. Currently, there is a relative paucity of studies concerning metastatic cutaneous SCC.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Topics
PubMed Articles
Jobs
JAMAevidence.com

Users' Guides to the Medical Literature
Melanoma

The Rational Clinical Examination
Make the Diagnosis: Melanoma

brightcove.createExperiences();